Finance

Lists
AFT:NZE
AFT Pharmaceuticals Ltd
4,59 NZ$
-1,08%
(-0,050) 1D
12 հոկ, 17:00:32 GMT+13  ·   NZD
All symbols
SymbolPriceChange% Change
Generating top insights for AFT...
Open
4,64 NZ$
High
4,64 NZ$
Low
4,50 NZ$
Mkt. cap
486,62 մլն
Avg. vol.
23,82 հզր
Volume
26,15 հզր
Dividend
0,54%
Quarterly dividend
0,01 NZ$
Ex-dividend date
18 հնս, 2026 թ.
P/E ratio
32,68
52-wk high
4,85 NZ$
52-wk low
2,85 NZ$
EPS
0,14 NZ$
Shares outstanding
104,87 մլն
No. of employees
126
Open
4,64 NZ$
High
4,64 NZ$
Low
4,50 NZ$
Mkt. cap
486,62 մլն
Avg. vol.
23,82 հզր
Volume
26,15 հզր
Dividend
0,54%
Quarterly dividend
0,01 NZ$
Ex-dividend date
18 հնս, 2026 թ.
P/E ratio
32,68
52-wk high
4,85 NZ$
52-wk low
2,85 NZ$
EPS
0,14 NZ$
Shares outstanding
104,87 մլն
No. of employees
126
News stories
From web sources and news partners
About AFT Pharmaceuticals Ltd
CEOHartley Atkinson
Employees126
Founded1997
Headquarters-
Sector-
Previous reportsAll values in NZD
Loading Previous Earnings...
Revenue
Net income
All values in NZD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
57,47 մլն
57,47 մլն
69,88 մլն
69,88 մլն
Cost of goods sold
32,63 մլն
32,63 մլն
39,45 մլն
39,45 մլն
Cost of revenue
32,63 մլն
32,63 մլն
39,45 մլն
39,45 մլն
Research and development expenses
3,06 մլն
3,06 մլն
1,86 մլն
1,86 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,10 մլն
19,10 մլն
18,83 մլն
18,83 մլն
Operating expense
22,48 մլն
22,48 մլն
20,58 մլն
20,58 մլն
Total operating expenses
55,10 մլն
55,10 մլն
60,03 մլն
60,03 մլն
Operating income
2,37 մլն
2,37 մլն
9,85 մլն
9,85 մլն
Other non operating income
462,50 հզր
462,50 հզր
-886,50 հզր
-886,50 հզր
EBT including unusual items
2,22 մլն
2,22 մլն
8,72 մլն
8,72 մլն
EBT excluding unusual items
2,22 մլն
2,22 մլն
8,72 մլն
8,72 մլն
Income tax expense
856,50 հզր
856,50 հզր
3,04 մլն
3,04 մլն
Effective tax rate
38,61%
38,61%
34,88%
34,88%
Other operating expenses
318,00 հզր
318,00 հզր
-113,00 հզր
-113,00 հզր
Net income
1,65 մլն
1,65 մլն
5,72 մլն
5,72 մլն
Net profit margin
2,87%
2,87%
8,18%
8,18%
Earnings per share
-
-
-
-
Interest and investment income
2,50 հզր
2,50 հզր
500,00
500,00
Interest expense
-615,00 հզր
-615,00 հզր
-628,00 հզր
-628,00 հզր
Net interest expenses
-612,50 հզր
-612,50 հզր
-627,50 հզր
-627,50 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
3,07 մլն
3,07 մլն
11,00 մլն
11,00 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps